Introduction The Global Epigenetics Market has emerged as one of the most dynamic sectors in biotechnology, driven by increasing scientific understanding of gene regulation and disease mechanisms. Epigenetics refers to the study of heritable changes in gene expression that do not involve alterations in the DNA sequence itself. These modifications—such as DNA methylation, histone...

Executive Summary 3D Reconstruction Technology Market : The 3D reconstruction technology market is expected to witness market growth at a rate of 9.15% in the forecast period of 2022 to 2029. Data Bridge Market Research report on 3D reconstruction technology market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecast period...

The advancement of trispecific antibodies is opening new doors in the field of cancer treatment. Unlike traditional monoclonal or bispecific antibodies, these novel agents are capable of engaging three distinct targets, which enhances immune cell activation and tumor cell recognition. As a result, trispecifics offer the potential for greater therapeutic precision and improved clinical...

Market Overview Intensity Modulated Radiotherapy Market size was valued at USD 1.70 billion in 2023. The market is anticipated to grow from USD 1.76 billion in 2024 to USD 2.59 billion by 2032, exhibiting the CAGR of 5.0% during the forecast period. The adoption of IMRT has been accelerating due to its ability to improve treatment outcomes, reduce side effects, and enhance...

Market Overview Intensity Modulated Radiotherapy Market size was valued at USD 1.70 billion in 2023. The market is anticipated to grow from USD 1.76 billion in 2024 to USD 2.59 billion by 2032, exhibiting the CAGR of 5.0% during the forecast period. The adoption of IMRT has been accelerating due to its ability to improve treatment outcomes, reduce side effects, and enhance...

Novartis’ LUTATHERA (lutetium Lu 177 dotatate) has already been a breakthrough in treating gastroenteropancreatic neuroendocrine tumors (GEP-NETs). With its approval now extended to pediatric patients, Novartis further strengthens its leadership in oncology. While the lutathera cost remains a central discussion point, this expansion underscores the therapy’s value in addressing...

The Emergence of PROTAC Technology In the realm of modern drug discovery, the term "PROTAC" has become increasingly prevalent. PROTAC stands for "Proteolysis Targeting Chimeras," a revolutionary technology that offers an innovative approach to degrading specific proteins within cells. Unlike traditional small-molecule drugs, which typically inhibit the function of a target protein, PROTACs work...

  The AACR Annual Meeting 2025 is a globally recognized event that brings together leading experts, researchers, and healthcare professionals to share groundbreaking discoveries in cancer research. As one of the most anticipated conferences in oncology, it provides a platform for unveiling the latest advancements in cancer treatments, diagnostics, and cutting-edge therapies. Attendees will...

The AACR Annual Meeting 2025 is a prestigious global event where leading oncologists, scientists, and industry pioneers come together to discuss groundbreaking advancements in cancer research. Organized by the American Association for Cancer Research (AACR), the conference covers cutting-edge innovations in immunotherapy, precision medicine, and targeted therapies. With expert discussions and...

Introspective Market Research proudly presents the comprehensive Ablation Devices Market Report, a detailed 250+ page analysis designed to provide you with deep insights into industry dynamics, emerging trends, and growth opportunities through 2032. This report offers a thorough exploration of the Ablation Devices market, covering product scope, competitive landscape, and regional market...